CC
CRMD icon

Centiva Capital’s CorMedix CRMD Stock Holding History

Centiva Capital’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,683
Closed -$242K – 1226
2025
Q2 		$242K Buy
+19,683
New +$217K ﹤0.01% 1259
2024
Q3 		– Sell
-31,787
Closed -$138K – 2220
2024
Q2 		$138K Buy
+31,787
New +$161K ﹤0.01% 1788
2023
Q4 		– Sell
-13,046
Closed -$48.3K – 1869
2023
Q3 		$48.3K Buy
+13,046
New +$51.9K ﹤0.01% 1605

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's CRMD Position: Q3 2025 in Review

Centiva Capital sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 19,683 shares — an estimated $242K sold.

Centiva Capital first reported a position in CRMD in Q3 2023 and held it in 3 quarters. The position peaked at $242K in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

  • Centiva Capital reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 19,683 CorMedix shares in Q3 2025, an estimated $242K.
  • Centiva Capital first reported a position in CorMedix in Q3 2023 and held it in 3 quarters.
  • Centiva Capital's CorMedix position peaked at $242K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.